Join the 'Systemic Candidiasis' group to help and get support from people like you.
Systemic Candidiasis News
Posted 4 Nov 2016 by Drugs.com
FRIDAY, Nov. 4, 2016 – Federal health officials say 13 cases of a potentially deadly, drug-resistant fungal infection have been reported in the United States. Four of those cases ended in death, but health officials said it's not clear if the deaths were due to the infection or the patients' underlying health conditions. Candida auris fungal infection is emerging as a health threat worldwide, and it appears to spread in hospitals and other health care facilities, according to the U.S. Centers for Disease Control and Prevention. "We need to act now to better understand, contain and stop the spread of this drug-resistant fungus," CDC Director Dr. Tom Frieden said in an agency news release. "This is an emerging threat, and we need to protect vulnerable patients and others." Of the 13 U.S. cases reported between May 2013 and August 2016, seven are described in the CDC's Nov. 4 Morbidity ... Read more
Related support groups: Infections, Fluconazole, Diflucan, Nystatin, Lamisil, Terbinafine, Clotrimazole, Ketoconazole, Miconazole, Candida Infections, Griseofulvin, Nizoral, Itraconazole, Amphotericin B, Sporanox, Voriconazole, Gris-PEG, Hydroxypropyl Chitosan/terbinafine, Mycostatin, Nilstat